60-Day Mortality Not Significantly Lower With ECMO in ARDS

FRIDAY, May 25, 2018 -- For patients with very severe acute respiratory distress syndrome (ARDS), 60-day mortality is not significantly lower with venovenous extracorporeal membrane oxygenation (ECMO) than with continued conventional treatment,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news